In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 75 for your search:
Drug:  temsirolimus
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3066K1-4438, B1771007, NCT01180049
2.

Phase: Phase IV
Type: Natural history/Epidemiology
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3066K5-4406, B1771015, NCT01210482
3.

Phase: Phase IV
Type: Natural history/Epidemiology
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: B1771016, NCT01420601
4.

Phase: Phase III
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: Esperanz-002, NCT01265810
5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR100848, PCI-32765MCL3001, 2012-000601-74, NCT01646021
6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N0572, N0572, NCT00329719
7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00284, MC0736, N01CM62205, CDR0000598057, MAYO-MC0736, 8129, NCT00699491
8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2008-0827, NCT00877773
9.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 09-0668 / 201105207, NCT00921310
10.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 1 and over
Sponsor: Other
Protocol IDs: J0963, NA_00028490, NCT00949325
11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-09117, IRB #09-117, 8147, NCT01026623
12.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: HN0209, NCT01015664
13.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 09-131, NCT01016769
14.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-09058, 09-058, 8249, NCT01051557
15.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-09-443-A, 09-443-A, 8309, NCT01076543
16.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 341, NCT01078142
17.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: WCTU-TOTEM, WCTU-TOTEM, ISRCTN31546330, EUDRACT-2007-007615-82, EU-21014, WCTU-SPON-417-07, CRUK-08/015, NCT01090466
18.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: 10-005, NCT01111825
19.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: C-II-007, 2010-018370-21, NCT01206036
20.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MRHCCTS2010, NCT01335074
21.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-E1A10, E1A10, NCT01381692
22.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: T³, NCT01389427
23.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MEL001, NCT01614301
24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-184, NCT00782275
25.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 201170, NCT00838955
1    
New Search